Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,654Revenue $M1.4Net Margin (%)-6,941.3Altman Z-Score80.7
Enterprise Value $M1,525EPS $-0.3Operating Margin %-7,746.9Piotroski F-Score4
P/E(ttm)--Beneish M-Score-4.2Pre-tax Margin (%)-6,941.3Higher ROA y-yN
Price/Book13.610-y EBITDA Growth Rate %-13.2Quick Ratio12.5Cash flow > EarningsY
Price/Sales1,2765-y EBITDA Growth Rate %-0.1Current Ratio12.5Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-145.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-185.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M128ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ZIOP

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ZIOPJoel Greenblatt 2015-03-31 Buy 0.01%$4.96 - $14
($9.88)
$ 12.9031%New holding109,080
ZIOPFirst Eagle Investment 2013-06-30 Sold Out $1.52 - $2.621
($1.85)
$ 12.90597%Sold Out0
ZIOPFirst Eagle Investment 2013-03-31 Buy $1.72 - $5.71
($4.42)
$ 12.90192%New holding200,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ZIOP is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ZIOP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LEBEL FRANCOISExecutive Vice President R&D 2015-06-09Sell50,000$10.1227.47view
BRENNAN MURRAYDirector 2015-06-04Sell40,000$9.732.99view
Lafond Kevin GVice Pres., Treasurer, & CAO 2015-06-03Sell57,500$9.6533.68view
KIRK RANDAL JDirector, 10% Owner 2015-02-09Buy1,440,000$8.7547.43view
KIRK RANDAL JDirector, 10% Owner 2013-10-29Buy2,857,143$3.5268.57view
KIRK RANDAL JDirector, 10% Owner 2012-01-20Buy1,923,075$5.2148.08view
KIRK RANDAL JDirector, 10% Owner 2011-08-23Buy38,294$4.99158.52view
KIRK RANDAL JDirector, 10% Owner 2011-08-22Buy461,646$4.92162.2view
Fowler WycheDirector 2011-08-10Buy5,000$5.19148.55view
KIRK RANDAL JDirector, 10% Owner 2011-08-09Buy846,522$4.78169.87view

Quarterly/Annual Reports about ZIOP:

News about ZIOP:

Articles On GuruFocus.com
Intrexon Corp is expanding his business Jun 25 2015 
Holdings Mar 31 2015 
Holdings Mar 31 2015 
Hayman Advisors Update - Second Quarter Sells and Company Results Aug 26 2013 
Bass’ New Buy – ZIOPHARM Oncology Inc. May 16 2013 
The Far-Off Four, 52-week Lows Held by Gurus May 11 2013 
comment on ZIOP Mar 15 2013 
cooldecency99 note on ZIOP May 01 2010 
ZIOPHARM Reports Second Quarter Financial Results and Updates Clinical Programs Aug 14 2009 

More From Other Websites
ZIOPHARM Announces Orphan Drug Designation for Ad-RTS-hIL-12 in the Treatment of Malignant Glioma Jul 24 2015
Will ZIOPHARM Oncology (ZIOP) Stock Decline After Analyst Downgrade? Jun 22 2015
Ziopharm Oncology Downgraded By BMO As 'Questions Persist' Jun 22 2015
ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 19 2015
ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jun 18 2015
Here’s why some investors think Ziopharm is poised for a $10B merger Jun 11 2015
ZIOPHARM ONCOLOGY INC Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Financial... Jun 08 2015
Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares Jun 05 2015
Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares Jun 05 2015
ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Jun 02 2015
ZIOPHARM Announces Caesar J. Belbel, Chief Legal Officer, Appointed Chief Operating Officer Jun 02 2015
5 Stocks Under $10 Ready to Spike Higher May 29 2015
ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... May 15 2015
ZIOPHARM ONCOLOGY INC Financials May 15 2015
10-Q for ZIOPHARM Oncology, Inc. May 09 2015
ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 07 2015
ZIOPHARM ONCOLOGY INC Files SEC form 10-Q, Quarterly Report May 07 2015
ZIOPHARM Reports First-Quarter 2015 Financial Results and Recent Activities May 07 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK